Daniel Rauh

47PUBLICATIONS
107CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Signal transductionMolecular targetsGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 29, 2026
Covalent-Allosteric Akt Inhibitors: Targeting Akt3 through Molecular Hybridization and Expanding the Isoform-Selective Toolbox.

|Sep 07, 2026
Isoform-Selective Targeting of Akt Through Covalent Allosteric Inhibition.

|Aug 06, 2026
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.

|Mar 02, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).

Giorgia Mancino, Tom Schulz, Andrea Scrima

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

Pageof 8

Frequent Collaborators

22 joint publications

Matthias Philipp Müller

11 joint publications

Jörn Weisner

8 joint publications

Tom Schulz

7 joint publications

Jonas Lategahn